Literature DB >> 12646284

RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice.

Susan B Powell1, Martin P Paulus, Deborah S Hartman, Thierry Godel, Mark A Geyer.   

Abstract

Novelty seeking as a behavioral phenomenon emerges as a compromise between approach and avoidance behavior. Although novelty seeking is thought to play a role in drug abuse and in cognition, the biological basis for this construct is poorly understood. At a genetic level, dopamine D4 receptors (D4R) appear to be critical for the behavioral expression of novelty seeking. In humans, polymorphisms of D4R have been associated with novelty-seeking traits in general and attention deficit-hyperactivity disorder in particular. Similarly, D4R (-/-) mice exhibit less novel object exploration than D4R (+/+) mice. Due to of the paucity of selective D4R ligands for use in behavioral pharmacology studies, few studies have examined the behavioral effects of D4R compounds in animals. The present experiments characterized RO-10-5824, a new, selective D4R partial agonist with minimal affinity for dopamine D2 and D3 receptors, and tested the hypothesis that activation of D4R increases the investigation by mice of a novel object placed in the center of a familiar open field. C57BL/6J and DBA/1J male mice were used in a dose response study of the selective D4R partial agonist RO-10-5824 (0, 1.0, 3.0, or 10.0 mg/kg). While having no effect on the amount of locomotor activity in novel or familiar environments, RO-10-5824 (10.0 mg/kg) increased time spent in the center of the enclosure in the presence of a novel object in C57 but not DBA mice. These results support the hypothesis that stimulation of D4R can enhance novelty seeking in mice and that this effect may be dependent on subtle genetic differences.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646284     DOI: 10.1016/s0028-3908(02)00412-4

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  20 in total

Review 1.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

2.  Design, synthesis, radiolabeling, and in vivo evaluation of carbon-11 labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a potential positron emission tomography tracer for the dopamine D(4) receptors.

Authors:  Enza Lacivita; Paola De Giorgio; Irene T Lee; Sean I Rodeheaver; Bryan A Weiss; Claudia Fracasso; Silvio Caccia; Francesco Berardi; Roberto Perrone; Ming-Rong Zhang; Jun Maeda; Makoto Higuchi; Tetsuya Suhara; John A Schetz; Marcello Leopoldo
Journal:  J Med Chem       Date:  2010-10-28       Impact factor: 7.446

3.  Behavioral and neurophysiological effects of Ro 10-5824, a dopamine D4 receptor partial agonist, in common marmosets.

Authors:  Shunsuke Nakazawa; Takeshi Murai; Masanori Miyauchi; Manato Kotani; Kazuhito Ikeda
Journal:  Psychopharmacology (Berl)       Date:  2015-06-05       Impact factor: 4.530

4.  High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.

Authors:  Andréy Mazarati; Mattia Maroso; Valentina Iori; Annamaria Vezzani; Mirjana Carli
Journal:  Exp Neurol       Date:  2011-08-22       Impact factor: 5.330

5.  Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548.

Authors:  David F Cummings; Spencer S Ericksen; Angela Goetz; John A Schetz
Journal:  J Pharmacol Exp Ther       Date:  2010-03-09       Impact factor: 4.030

6.  F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.

Authors:  R Depoortère; A L Auclair; L Bardin; L Bruins Slot; M S Kleven; F Colpaert; B Vacher; A Newman-Tancredi
Journal:  Br J Pharmacol       Date:  2007-03-20       Impact factor: 8.739

Review 7.  Dopamine D4 receptors in psychostimulant addiction.

Authors:  Patricia Di Ciano; David K Grandy; Bernard Le Foll
Journal:  Adv Pharmacol       Date:  2014

8.  D4 receptor deficiency in mice has limited effects on impulsivity and novelty seeking.

Authors:  C M Helms; N R Gubner; C J Wilhelm; S H Mitchell; D K Grandy
Journal:  Pharmacol Biochem Behav       Date:  2008-03-28       Impact factor: 3.533

9.  Attention-Deficit Hyperactivity Disorder in the post-genomic era.

Authors:  Philip Asherson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

10.  A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus.

Authors:  Valerio Mammoli; Alessandro Bonifazi; Diego Dal Ben; Mario Giannella; Gianfabio Giorgioni; Alessandro Piergentili; Maria Pigini; Wilma Quaglia; Ajiroghene Thomas; Amy H Newman; Sergi Ferré; Marta Sanchez-Soto; Thomas M Keck; Fabio Del Bello
Journal:  ChemMedChem       Date:  2016-03-15       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.